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Abstract 
Whole exome sequencing has established IQSEC2 as a neurodevelopmental disability 
gene.  The IQSEC2 variant phenotype includes developmental delay, intellectual 
disability, epilepsy, hypotonia, autism, developmental regression, microcephaly and 
stereotypies but is yet to be fully described.  Presented here, are 14 new patients with 
IQSEC2 variants.  In addition to the established features, we observed: gait ataxia in 7/9 
(77.8%), drooling in 9/14 (64.2%), early feeding difficulties in 7/14 (50%), structural brain 
abnormalities, in 6/13 (46.2%), brachycephaly in 5/14 (35.7%), and scoliosis and 
paroxysms of laughter, each in 4/14 (28.6%).  We suggest that these are features of the 
IQSEC2-related disorder.  Gastrostomy requirement, plagiocephaly, strabismus and 
cortical blindness, each seen in 2/14 (14.3%) may also be associated.  Shared facial 
features were noted in 8/14 patients and shared hair patterning was identified in 4/14 
patients.   
This study further delineates the IQSEC2 phenotypic spectrum and supports the notion of 
an emerging IQSEC2 syndrome.  We draw parallels between the IQSEC2-related 
disorder and the Angelman- / Rett- / Pitt-Hopkins syndrome group of conditions and 
recommend the addition of IQSEC2 to epilepsy- and developmental delay gene panels.  
We observed discordant phenotypes in monozygotic twins and apparent gonadal 
mosaicism, which has implications for recurrence risk counselling in the IQSEC2-related 
disorder. 
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Introduction 
The IQ motif and Sec7 domain 2 (IQSEC2) gene (OMIM #300522), located at 
chromosome Xp11.22, has recently been identified as an important neurodevelopment 
gene by next generation sequencing studies.  85 cases or families with IQSEC2 variants 
have been previously described in the medical literature, however, detailed case studies 
of only about 30 patients with IQSEC2 variants have so far been reported and the 
phenotype has not yet been fully delineated. 
IQSEC2 was first ascertained as a gene of neurodevelopment in 2008, when a girl with 
infantile spasms, profound developmental delay and severe intellectual disability was 
found to have a chromosomal translocation with a break point disrupting the first intron of 
IQSEC2(1).  Murine studies demonstrated that the IQSEC2 protein (also known as 
BRAG1) is expressed in the central nervous system in early development(1).  IQSEC2 is 
one of the most abundant proteins in the post synaptic density of glutaminergic neurons -
more so than N-methyl-D-DVSDUWDWH10'$UHFHSWRUVRUĮ-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors, implying that it is of crucial importance in post 
synaptic transmission(2).      
The established features of patients with IQSEC2 variants are global developmental 
delay, intellectual disability, epilepsy, microcephaly, hypotonia, language regression, 
social communication deficits and stereotypic hand movements(3).  In one study, 7/9 
patients with IQSEC2 variants who underwent Magnetic Resonance Imaging (MRI) of the 
brain demonstrated abnormal -but non-specific- MRI appearances(4). 
Much of the literature on humans with IQSEC2 variants takes the form of sequencing and 
reporting variants in patients with epilepsy.  In this, the joint second largest IQSEC2 
phenotyping study to date, we present 14 new patients with IQSEC2 variants, identified 
through the Deciphering Developmental Disorders (DDD) study and further delineate the 
features of the IQSEC2-related disorder. 
This article is protected by copyright. All rights reserved. 
A
cc
ep
te
d
 A
rt
ic
le
 Materials and methods 
Patients with a wide range of neurodevelopmental problems were recruited to the DDD 
study(5), with trio whole exome sequencing performed as previously described(6).  All 
patients had had an uninformative chromosomal microarray prior to recruitment.  IQSEC2 
(NM_001111125.2) variants identified were validated by targeted Sanger sequencing. 
An application to the DDD study for a complimentary analysis project was successfully 
made, allowing access to anonymised details of patients with IQSEC2 variants identified 
through DDD on the Decipher website(7).  Clinicians of selected patients were contacted 
to invite patients and their families to be recruited. Excluded from the study were: patients 
with an additional proven genetic diagnosis, those with a chromosomal anomaly and 
those in whom IQSEC2 variants were of unknown inheritance or unknown clinical 
significance, with the exception of two cases, where the clinician had a high degree of 
suspicion that the variant was causative.   
The clinical significance of the variants identified was interpreted according to the 
guidelines set out by the American College of Medical Genetics(8). 
Written consent for SDWLHQWV¶ FOLQLFDO GHWDLOV DQG SKRWRJUDSKV WR EH used in journal 
publication was provided by the parents of the patients.   
Results 
Fourteen patients with variants in the IQSEC2 gene were recruited.  Seven were 
reviewed in clinic for deep phenotyping by the first author and the responsible clinician.  
For the others, comprehensive data were collected from the responsible clinicians.  
Clinical information for each patient is detailed in the supplementary information. 
Eight recruits were female and 6 were male.  Eleven had a de novo variant and 1 had a 
maternally inherited variant.  Two patients were monozygotic twins.  Two patients were 
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brothers but the IQSEC2 variant was not identified in their mother¶VEORRGVDPSOH.  Ten 
recruits were reported as having a pathogenic- or likely pathogenic- variant and two had 
a variant reported as being of uncertain clinical significance, but with a phenotype 
consistent with that of the IQSEC2-related disorder and suspected by the responsible 
clinician to be causative of the disorder.  
Amongst this cohort, there were no consanguineous parental unions.  There was an 
increase in nuchal translucency in one case  7ZR UHFUXLWV ZHUH ERUQ DW  ZHHNV¶
gestation and the remaining singletons were born at 37- ZHHNV¶ JHVWDWLRQ  $OO
singleton recruits had birth weights between 9th and 99th centiles.  Their post natal 
heights were variable, between 0.4th and 75th centiles.   
14/14 recruits (100%) had developmental delay and intellectual disability, which was 
severe or profound in all except one case (patient 7, who had moderate intellectual 
disability).  The other features were: epilepsy, in 11/14 (78.6%), ataxic gait, in 7/9 who 
were able to walk (77.8%), stereotypies, in 10/14 (71.4%), drooling and post natal 
microcephaly (defined as third centile or below), each in 9/14 (64.2%), constipation and 
tone abnormality, each in 8/14 (57.1%), developmental regression in at least 7/14 (50%), 
hypotonia and feeding difficulties, each in 7/14 (50%), variable structural brain 
abnormalities, in 6 of 13 who underwent brain MRI (46.2%), gastro-eosophageal reflux, in 
6/14 (42.9%), brachycephaly and autism, each in 5/14 (35.7%), scoliosis, paroxysms of 
laughter and eczema, each in 4/14 (28.6%), and plagiocephaly, cortical blindness and 
gastrostomy requirement, each in 2/14 (14.3%). 
Epilepsy was generally diagnosed between the ages of 1 and 3 years in this cohort.  The 
patients showed a variety of different seizure types, although generalised tonic-clonic 
was the most common.  Control of the seizures ranged from completely controlled to 
intractable.  Two of the 3 patients who did not have seizures had a history of vacant 
episodes.  Stereotypies included teeth gnashing, bruxism, hand flapping, hand shaking, 
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KDQG ZULQJLQJ KDQG µZLSLQJ¶ KHDGEDQJing, head shaking and rocking.  Most patients 
who had stereotypies displayed more than one type.  
The most commonly requested genomic investigations prior to recruitment to the DDD 
study were for Angelman syndrome and Rett syndrome, each in 5/14 (35.7%).    
X inactivation studies on patients 6 and 7 and the mother of patient 5 showed no 
evidence of skewed X inactivation. 
Features of patients in this cohort are summarised in table 1. 
[insert IQSEC2 table patients 1-7 followed by IQSEC table patients 8-14] 
Photographs of the patients are shown in figure 1. 
[insert figure 1] 
 
Discussion 
Delineating the phenotype 
Developmental delay and intellectual disability were the most prevalent features of this 
cohort, affecting all recruits.  Also highly prevalent in this cohort were: stereotypies, 
epilepsy, microcephaly, developmental regression, hypotonia and autism- in agreement 
with previous reports(1),(4),(9),(10),(11).    
Drooling and paroxysms of laughter, present in 64.2% and 28.6%, respectively, in this 
cohort, have not been previously reported in association with IQSEC2 variants and 
appear likely to represent important features of the condition.  Drooling in this cohort may 
be due to oral motor dysfunction and hypotonia.   
There has only been one report each in the published literature of ataxia(12) and 
brachycephaly(9), present in 77.8% and 28.6%, respectively in this cohort.  None of the 
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patients with ataxia had cerebellar abnormalities on the MRI that could account for their 
ataxic gait.   
Structural brain abnormalities, present in 46.2% were common in recruits to this study, in 
agreement with previous reports(4),(9).  There did not appear to be any definite correlation 
between the presence of a structural brain abnormality and the extent of developmental 
delay, sex of the patient, type of variant present or whether or not microcephaly was 
present.  Scoliosis and early feeding difficulties, present in 28.6% and 50%, respectively 
were also prevalent in this cohort.   There have been previous reports of scoliosis in three 
individuals with IQSEC2 variants(4),(13) and feeding difficulties have also been previously 
reported in three patients with IQSEC2 variants(13),(1),(10), including one who required a 
gastrostomy(13).  The findings, taken together with previous reports suggest that these 
features are likely to form part of the IQSEC2-related disorder.  The requirement for 
gastrostomy feeding in two patients in this cohort was likely due to a combination of 
developmental delay / intellectual disability, hypotonia and oral motor dysfunction.  These 
patients did not have early feeding difficulties, implying that early feeding difficulties are 
not an indicator of the likelihood of requiring gastrostomy feeding later in childhood in the 
IQSEC2-related disorder. 
Plagiocephaly, cortical blindness and strabismus were also found in 16.7% of this cohort 
and may be associated with the disorder.  Amongst individuals with IQSEC2 variants, 
cortical blindness has not been previously reported; plagiocephaly has been previously 
reported in two patients(9) and strabismus has previously been reported in 16 
individuals(4),(11),(13),(1),(9),(10),(14),(15).   
Constipation, gastro-oesophageal reflux and eczema, whilst common in all children 
appeared to be over-represented in recruits to this study.  Amongst individuals with 
IQSEC2 variants, gastro-oesophageal reflux has only been reported in one case(15) and 
constipation and eczema have not been reported but data from this study support an 
association.   
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Many patients did not have their occipital frontal circumference (OFC) at birth 
documented.  However, patients 2,10,12 and 14, who had serial OFC measurements in 
their early childhood, GHPRQVWUDWHD µFURVVLQJ RI WKH FHQWLOHV¶ towards 0.4th centile and 
provide evidence that the microcephaly seen in the IQSEC2-related disorder is, at least in 
some cases, secondary microcephaly.  This is consistent with a previous report(13).  
Secondary microcephaly in individuals with IQSEC2 variants implies a brain growth 
deceleration phase following birth and this may be extremely marked, as demonstrated 
by the serial measurements of patients 12 and 14. 
Regression of development is frequently observed in children with seizures.  The 
observations that patient 3 displayed regression prior to the onset of seizures and patient 
5 lost skills despite not having seizures provides evidence that regression of development 
is a distinct feature of the IQSEC2-related disorder, rather than merely being the 
consequence of epilepsy.  It is likely to be difficult to assess for developmental regression 
in patients who have not achieved any speech or significant motor skills beyond a social 
smile.  
Posterior urethral valves (patient 5) and precocious puberty (patient 11) have not been 
previously reported in the context of an IQSEC2 variant and it remains to be seen 
whether or not they form part of the condition. 
In previous reports, dysmorphic facial features were present in some individuals with 
IQSEC2 variants and not others.  The same was true of this cohort.  When the clinical 
photographs of the patients were reviewed together, common facial features were 
observed.  Patients 2, 3, 6 and 12 were noted to have deep-set eyes.  Patients 2, 3, 4, 5, 
6, 9, 12 and 13 had full lips.  Patients 2, 6, 12, 13 and 14 had a frontal upsweep of hair.  
Whilst there is not a very obvious gestalt for the IQSEC2 syndrome, the facial features 
and hair patterning, together with the presenting clinical problems may provide clues to 
the clinician as to the diagnosis in the child with an undiagnosed IQSEC2 variant. 
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Males in this cohort had more significant motor delay, intellectual disability and visual 
impairment than the females.  It is thought that males with loss of function variants 
always present with severe intellectual disability, epilepsy and are non-verbal(16) and this 
was supported by our findings.  Interestingly, females in this cohort were more likely than 
the males to receive a diagnosis of autism; this is likely because the extent of the 
disability in males might preclude the possibility of assessment for autism.  Male patient 2 
and female patient 4 have the same variant, however patient 2 has much more severe 
developmental delay.  (Patient 4 first sat independently at 12 months and walked at 23 
months and was able, at her best, to speak many words and use cutlery, whereas patient 
2 is yet to sit up unaided at the age of 6 years and is non-verbal).  Also the female twins 
(patients 6 and 7) harboured the same variant as the brothers (patients 13 and 14), 
however the brothers had more significant physical and intellectual disability than the 
girls.  Comparison of these patients provides further evidence for a more severe male 
phenotype.   
Tran Mau-Them et al. hypothesised that patients with truncating IQSEC2 variants have a 
more severe phenotype when compared to those with missense variants(11), suggesting 
that the phenotype arises due to loss of function.  It has been suggested that abolition 
(rather than a reduced level) of enzymatic activity of IQSEC2 typically leads to a more 
severe phenotype, including epileptic encephalopathy in both sexes(11).  However, this is 
not necessarily the case in this cohort, with patient 3 avoiding epileptic encephalopathy, 
despite having absent IQSEC2 protein; and patient 2 having a very severe phenotype, 
despite his variant being a missense (albeit in the critical sec7 domain).  These 
observations support the notion that it is the sex of the patient and/or the protein domain 
disrupted by the variant that is more predictive of the severity of the phenotype.   
Patient 5, who has severe intellectual disability but no seizures, has a variant of uncertain 
clinical significance (VUS) in a region of IQSEC2 not known to be of functional 
importance.  Previously, missense variants have been reported in males with severe 
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intellectual disability but not seizures(11),(17).  The fact that the mother of patient 5 (with 
normal intelligence) had a normal X inactivation pattern does not exclude pathogenicity of 
his variant because inheritance of IQSEC2 missense variant from a non-epileptic, normal 
intelligence female has been reported(13), as has inheritance from females with only mild 
learning difficulties(18),(19),(16).  The variants of patients 1 and 5 have not been previously 
reported and there does remain some uncertainty as to their pathogenicity.  However, 
many IQSEC2 missense variants in regions not known to be functional have been 
described in patients with intellectual disability, with or without epilepsy(16).  If these 
variants are shown to be causative of their disorder, then this implies that there exist 
other, as yet unrecognised important functional domains of the IQSEC2 protein.  
Explaining the female IQSEC2 phenotype 
It has been challenging to find an explanation for the IQSEC2 phenotype in females(4),(16), 
JLYHQ WKDW IHPDOHV FDQ KDYH D VHYHUH SKHQRW\SH GHVSLWH KDYLQJ D µEDFN XS¶ ;
chromosome.  It has been suggested that, in females, haploinsufficiency is sufficient to 
produce the full phenotype or alternatively, these variants produce a dominant negative 
effect.  These mechanisms imply X-linked dominance, so it is difficult to explain then, how 
some females with IQSEC2 missense variants have a normal- or near normal phenotype, 
which would imply X-linked recessive inheritance.  This raises the possibility that IQSEC2 
variants can show X-linked dominant or X-linked recessive inheritance and this may 
depend on the type of variant (missense versus nonsense or frameshift). 
IQSEC2 LVZLGHO\TXRWHGLQWKHOLWHUDWXUHWRµHVFDSH¶X inactivation (i.e. is expressed from 
both copies of the X chromosome in females),  based on the findings of Tsuchiya et al.(20) 
and Cotton et al.(21), although IQSEC2 is not specifically mentioned in these papers.  This 
view seemed to be in agreement with the finding that IQSEC2 is expressed in very similar 
levels in human female and male brain(22).  However, other work had shown that IQSEC2 
is X-inactivated(23) and X-inactivation studies cast doubt on the escape theory.  Of the 4 
patients in the literature where X inactivation studies have been performed on samples of 
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females with IQSEC2 variants, one had unfavourable skewing of 100:0 in blood(1), two 
others had severely unfavourably skewed X inactivation (100:0 and 97:3)(4) and a fourth 
had normal (66:34) X inactivation(4).  That skewed X inactivation is a principal moderator 
of phenotype in the IQSEC2-related disorder was not supported by the results of X 
inactivation studies performed on patients 6 and 7 and of the mother of patient 5 in this 
study.  However, this is a small sample size and these results may not reflect the pattern 
of X inactivation in other tissues.  It may be that IQSEC2 may be variably inactivated(16), 
as is known to be the case for many other genes. 
The IQSEC2-related disorder mimics other syndromes 
There is a  well-documented similarity in phenotype of individuals with IQSEC2 variants 
and Rett syndrome(11),(4),(24).  In agreement with this, 5 (35.7%) of this cohort had had 
MECP2 analysis, prior to the identification of the IQSEC2 variant.   
Other genes noted to have a phenotypic overlap with the IQSEC2-related disorder 
include FOXG1, CDKL5 and MEF2C(24).  Consistent with this, was the fact that one 
sample from this cohort had MEF2C testing prior to the identification of the SDWLHQW¶V 
IQSEC2 variant, one other underwent analysis of FOXG1 analysis and three others 
underwent CDKL5 analysis.  CDKL5 and IQSEC2 are expressed in the same areas of 
the brain, suggesting a functional link between the two proteins(1). 
Five (35.7%) patients in this cohort had been previously tested for Angelman syndrome.  
A phenotypic overlap of those with IQSEC2 variants and Angelman syndrome has not 
been previously discussed in the medical literature, although Morleo et al. noted that 
there was partial overlap with the Angelman phenotype in their patient(1) and some 
patients with IQSEC2 variants were noted to have had prior genomic analysis for 
Angelman syndrome(13),(11),(24).  Since 5-10% of patients with suspected Angelman 
syndrome do not have the classical associated chromosome 15q11 methylation changes 
or UBE3A variant(14), IQSEC2 analysis in patients with an Angelman-like phenotype may 
represent an opportunity for diagnosis of the IQSEC2-related disorder.  This may be 
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more relevant for female patients, since most patients with Angelman syndrome learn to 
walk and males with IQSEC2 variants often do not, although two patients tested for 
Angelman syndrome in this cohort were male.  In males, the overlap is most likely to be 
greater at a younger age, following which the phenotypes of Angelman syndrome and the 
IQSEC2-related disorder diverge.   
IQSEC2 is included on some -but not all- developmental delay gene panels or subpanels 
available in the UK.  Most epilepsy panels do not include IQSEC2(25).  The addition of 
IQSEC2 to these panels is likely to reveal more cases of the IQSEC2-related disorder. 
Gonadal mosaicism 
The finding of the same IQSEC2 variant in samples from patients 13 and 14 but not their 
PRWKHU¶V VDPSOH LPSOLHV What their mother displays gonadal mosaicism for the IQSEC2 
variant.  There has been one previous report of gonadal mosaicism in a family with the 
IQSEC2-related disorder(26).  We therefore recommend that parents of a child with the 
IQSEC2-related disorder should be counselled for the potential for gonadal mosaicism 
and the potential recurrence risk (which currently cannot be quantified) in subsequent 
pregnancies.   
Twin phenotype discordance   
The phenomenon of twin discordance for features of the IQSEC2-related disorder has not 
been reported previously.  Patient 6 has profound intellectual disability with epilepsy and 
aggressive / self-injurious behaviour, whereas her monozygotic twin sister, patient 7, has 
a much milder phenotype, with the ability to attend a mainstream school until the age of 
10 years.  Indeed, patient 7 had never been referred to a community paediatrics or 
genetics clinic prior to the identification of the IQSEC2 variant in her twin sister.  The 
twins were also discordant for other features distinct from the IQSEC2 phenotype, 
namely birth weight, face shape, patency of the ductus arteriosus and weight.  
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Monozygotic twins are not truly identical and X inactivation and imprinting are known to 
be discordant in some monozygotic twin pairs(27) (non-concordance for Beckwith±
Wiedemann syndrome amongst monozygotic twins is a well-known example(27)).  
Hogenson(28) argues that epigenetic alterations are the principal mechanism responsible 
for twin discordance.  Machin(27) provides many examples from the medical literature of 
monozygotic twins discordant for genetic conditions, most of which are not explained by a 
post zygotic variant in the affected twin.  The value of studying discordant monozygotic 
twin sets to investigate the effects of epigenetic alterations has been realised(29) and 
epigenetic findings from disease-discordant monozygotic twin studies so far have 
identified DNA methylation changes in multiple genes across a wide range of conditions.  
Epigenetic mechanisms, examples of which include DNA methylation, histone 
acetylation, chromatin remodelling and microRNA expression, induce or suppress gene 
expression, potentially altering the phenotype.  Epigenetic alterations are often caused by 
an environmental influence and are dynamic throughout life.  PDWLHQW¶VGHYHORSPHQWDO
milestones were mostly normal, implying that any epigenetic change responsible for her 
attenuated phenotype occurred in very early life or in utero. 
Twin non-concordance can, in some cases be explained by the non-equal allocation to 
each twin of stem cells after formation of the blastomere(27), which may have important 
implications for the cascade of developmental events during embryogenesis(30).  
Weksberg et al.(30) hypothesize that post zygotic events may lead to the formation of two 
or more cell clones in the inner cell mass of the embryo and that this actually precipitates 
the twinning event.  Other potential explanations for twin discordance in this cohort 
include post zygotic or somatic single nucleotide polymorphisms, that either directly ±and 
coincidentally- affect IQSEC2 or proteins with which it interacts, or themselves cause the 
alteration of epigenetic marks(29).    
The observation that DNA methylation profiles are less alike within pairs of 
monochorionic, monozygotic twins compared to pairs of dichorionic, monozygotic twins 
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suggests that sharing a placenta may cause unequal conditions in fetal life and therefore 
more discordant epigenetic profiles(29).  It remains unknown whether or not the putative 
twin-to-twin transfusion played a role in differing epigenetic profiles or contributed to the 
disparity in phenotype. 
Future Therapies 
Recently, the goal of curing genetic diseases has edged closer to becoming a reality, with 
the discovery and utilisation of the CRISPR (clustered regularly interspaced short 
palindromic repeats) Cas9 system to repair missense variants and cure genetic 
disease(31).  The finding that the shorter IQSEC2 isoform, shows continued and 
increasing expression in post natal life(32) offers hope that amelioration of the severity of 
the IQSEC2 phenotype may be possible by means of repairing of missense variants in 
IQSEC2 or using drug therapy to inhibit epigenetic marks.  The latter would depend on 
the identification of epigenetic marks that are capable of moderating the phenotype in this 
disorder.  Secondary microcephaly in individuals with IQSEC2 variants implies a brain 
growth deceleration phase following birth (in at least some cases), meaning that there 
may be a window of opportunity early in life in which to treat these individuals with any 
such targeted therapy.     
Conclusion 
 The data from this study provide evidence for several new features of the IQSEC2-
related disorder and support the notion of an emerging IQSEC2 syndrome.  We echo a 
previous recommendation by Helm and colleagues(13) to consider requesting IQSEC2 
analysis in all patients with severe intellectual disability and seizures or a phenotype 
resembling Rett syndrome.  In addition, we suggest that firstly, the possibility of the 
presence of an IQSEC2 variant is also considered in patients with an Angelman- / Pitt-
Hopkins-like phenotype and secondly, that IQSEC2 should be added to epilepsy- and 
developmental delay / intellectual disability panels.  As whole exome- and whole genome 
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sequencing become more widely available, it is likely that an increasing number of 
IQSEC2 variants will be identified.  
The observation of apparent gonadal mosaicism in this cohort has implications for 
genetic counselling of parents with an affected child.   
The observation of twin discordance in phenotype in this study offers hope for the 
possible development of a therapy to mitigate the severity of the IQSEC2 phenotype. 
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Figure 1: Photographs of patients in this study.  Patients 6 and 7 are monozygotic twins.  Patients 13 and 
14 are brothers.  Patients 1 and 5 are the patients with the missense variants.  Patients 2, 3, 4, 6, 10, 12 
and 13 were noted to have full lips.  Patients 2, 3, 10 and 12 had deeply-set eyes.  Patients 2, 6, 12, 13 and 
14 had frontal upsweeps of hair.   
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Table 1: summary of genotype, phenotype and previous genomic analysis for each patient.   
Key: PVL = periventricular leucomalacia. 
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